First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Chapter 4: pre-clinical efficacy and complication data required to justify a c-Reference-Cited by-同舟云学术

First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Chapter 4: pre-clinical efficacy and complication data required to justify a c

Published:2016-01 Issue:1 Volume:23 Page:46-52
ISSN:0908-665X
Container-title:Xenotransplantation
language:en
Short-container-title:Xenotransplantation

Author:

Cooper David K.C.¹,Bottino Rita²,Gianello Pierre³,Graham Melanie⁴,Hawthorne Wayne J.⁵,Kirk Allan D.⁶,Korsgren Olle⁷,Park Chung-Gyu⁸,Weber Collin⁹

Affiliation:

1. Thomas E. Starzl Transplantation Institute; Pittsburgh PA USA

2. Institute for Cellular Therapeutics; Allegheny-Singer Research Institute; Pittsburgh PA USA

3. Faculté de Medecine; Laboratory of Experimental Surgery; Université Catholique de Louvain; Brussels Belgium

4. Department of Surgery; Preclinical Research Center; University of Minnesota; St. Paul MN USA

5. Department of Surgery; University of Sydney at Westmead Hospital; Westmead NSW Australia

6. Department of Surgery; Duke University Medical School; Durham NC USA

7. Department of Immunology, Genetics, and Pathology; Uppsala University; Uppsala Sweden

8. Department of Microbiology and Immunology; Department of Biomedical Sciences; Xenotransplantation Research Center; College of Medicine; Seoul National University; Seoul South Korea

9. Department of Surgery; Emory University School of Medicine; Atlanta GA USA

Publisher

Wiley

Subject

Transplantation,Immunology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/xen.12226/fullpdf

Reference27 articles.

1. World Health Organization The Changsha Communique First WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials Changsha, China, November 19-21 2008

2. Global consultation on regulatory requirements for xenotransplantation in clinical trials. Conference held in Changsha, China, November 19-21, 2008;Cooper;Xenotransplantation,2009

3. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - executive summary;Hering;Xenotransplantation,2009

4. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial;Cooper;Xenotransplantation,2009

5. Toward clinical islet xenotransplantation - are revisions to the IXA guidelines warranted?;Cooper;Xenotransplantation,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term control of diabetes by tofacitinib‐based immunosuppressive regimen after allo islet transplantation in diabetic rhesus monkeys that rejected previously transplanted porcine islets;Xenotransplantation;2024-03

2. Cellular Immune Responses in Islet Xenograft Rejection;Frontiers in Immunology;2022-07-07

3. Ethics and Theoretical Issues in Kidney Xenotransplantation;Seminars in Nephrology;2022-07

4. Xenotransplantation of Genetically Modified Neonatal Pig Islets Cures Diabetes in Baboons;Frontiers in Immunology;2022-06-16

5. Xenogeneic pancreatic islet cell transplantation—Application of pig cells and techniques for clinical islet cell xenotransplantation;Pancreas and Beta Cell Replacement;2022